Healthy volunteers
Conditions
Interventions
None listed
Sponsors
Novartis Pharma AG
Eligibility
Sex/Gender
Male
Age
18 Years to 64 Years
Outcome results
None listed
A Phase I, open-label, non-randomized study to assess the absorption, distribution, metabolism and excretion (ADME) and pharmacokinetics of LTP001 following a single oral dose of [14C]LTP001 in healthy male participants
For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms
Source: EU CTIS · Data processed: Mar 7, 2026